Allicin has also been identified as a potential preventive agent for obesity and related metabolic diseases by increasing the expression of brown adipocyte-specific genes such as UCP-1 through the KLF15 signaling cascade [40]. The gene discussed is UCP1; the disease is obesity disorder.